Search results:

Gene ID	Symbol	Synonyms	Official Full Name	Location
The pahtway p165 has 70 genes in the original annotation. Currently, there are 56 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
5599	MAPK8	JNK \| JNK-46 \| JNK1 \| JNK1A2 \| JNK21B1/2 \| PRKM8 \| SAPK1 \| SAPK1c	mitogen-activated protein kinase 8	10q11.22
1147	CHUK	IKBKA \| IKK-alpha \| IKK1 \| IKKA \| NFKBIKA \| TCF16	conserved helix-loop-helix ubiquitous kinase	10q24-q25
7423	VEGFB	VEGFL \| VRF	vascular endothelial growth factor B	11q13
5970	RELA	NFKB3 \| p65	v-rel avian reticuloendotheliosis viral oncogene homolog A	11q13
595	CCND1	BCL1 \| D11S287E \| PRAD1 \| U21B31	cyclin D1	11q13
3845	KRAS	C-K-RAS \| CFC2 \| K-RAS2A \| K-RAS2B \| K-RAS4A \| K-RAS4B \| KI-RAS \| KRAS1 \| KRAS2 \| NS \| NS3 \| RALD \| RASK2	Kirsten rat sarcoma viral oncogene homolog	12p12.1
1019	CDK4	CMM3 \| PSK-J3	cyclin-dependent kinase 4	12q14
675	BRCA2	BRCC2 \| BROVCA2 \| FACD \| FAD \| FAD1 \| FANCD \| FANCD1 \| GLM3 \| PNCA2 \| XRCC11	breast cancer 2	13q12.3
5925	RB1	OSRC \| PPP1R130 \| RB \| p105-Rb \| pRb \| pp110	retinoblastoma 1	13q14.2
7043	TGFB3	ARVD \| ARVD1 \| LDS5 \| RNHF \| TGF-beta3	transforming growth factor beta 3	14q24
5228	PGF	D12S1900 \| PGFL \| PLGF \| PlGF-2 \| SHGC-10760	placental growth factor	14q24.3
207	AKT1	AKT \| CWS6 \| PKB \| PKB-ALPHA \| PRKBA \| RAC \| RAC-ALPHA	v-akt murine thymoma viral oncogene homolog 1	14q32.32
5604	MAP2K1	CFC3 \| MAPKK1 \| MEK1 \| MKK1 \| PRKMK1	mitogen-activated protein kinase kinase 1	15q22.1-q22.33
5595	MAPK3	ERK-1 \| ERK1 \| ERT2 \| HS44KDAP \| HUMKER1A \| P44ERK1 \| P44MAPK \| PRKM3 \| p44-ERK1 \| p44-MAPK	mitogen-activated protein kinase 3	16p11.2
23533	PIK3R5	F730038I15Rik \| FOAP-2 \| P101-PI3K \| p101	phosphoinositide-3-kinase regulatory subunit 5	17p13.1
7157	TP53	BCC7 \| LFS1 \| P53 \| TRP53	tumor protein p53	17p13.1
2064	ERBB2	CD340 \| HER-2 \| HER-2/neu \| HER2 \| MLN 19 \| NEU \| NGL \| TKR1	erb-b2 receptor tyrosine kinase 2	17q12
6774	STAT3	ADMIO \| APRF \| HIES	signal transducer and activator of transcription 3 (acute-phase response factor)	17q21.31
10928	RALBP1	RIP1 \| RLIP1 \| RLIP76	ralA binding protein 1	18p11.3
4087	SMAD2	JV18 \| JV18-1 \| MADH2 \| MADR2 \| hMAD-2 \| hSMAD2	SMAD family member 2	18q21.1
4089	SMAD4	DPC4 \| JIP \| MADH4 \| MYHRS	SMAD family member 4	18q21.1
7040	TGFB1	CED \| DPD1 \| LAP \| TGFB \| TGFbeta	transforming growth factor beta 1	19q13.1
208	AKT2	HIHGHH \| PKBB \| PKBBETA \| PRKBB \| RAC-BETA	v-akt murine thymoma viral oncogene homolog 2	19q13.1-q13.2
5296	PIK3R2	MPPH \| MPPH1 \| P85B \| p85 \| p85-BETA	phosphoinositide-3-kinase regulatory subunit 2	19q13.2-q13.4
3716	JAK1	JAK1A \| JAK1B \| JTK3	Janus kinase 1	1p32.3-p31.3
8503	PIK3R3	p55 \| p55-GAMMA \| p55PIK	phosphoinositide-3-kinase regulatory subunit 3	1p34.1
1870	E2F2	E2F-2	E2F transcription factor 2	1p36
998	CDC42	CDC42Hs \| G25K \| TKS	cell division cycle 42	1p36.1
5293	PIK3CD	APDS \| IMD14 \| P110DELTA \| PI3K \| p110D	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta	1p36.2
842	CASP9	APAF-3 \| APAF3 \| ICE-LAP6 \| MCH6 \| PPP1R56	caspase 9	1p36.21
10000	AKT3	MPPH \| MPPH2 \| PKB-GAMMA \| PKBG \| PRKBG \| RAC-PK-gamma \| RAC-gamma \| STK-2	v-akt murine thymoma viral oncogene homolog 3	1q44
598	BCL2L1	BCL-XL/S \| BCL2L \| BCLX \| Bcl-X \| PPP1R52	BCL2 like 1	20q11.21
5594	MAPK1	ERK \| ERK-2 \| ERK2 \| ERT1 \| MAPK2 \| P42MAPK \| PRKM1 \| PRKM2 \| p38 \| p40 \| p41 \| p41mapk \| p42-MAPK	mitogen-activated protein kinase 1	22q11.21
5880	RAC2	EN-7 \| Gx \| HSPC022 \| p21-Rac2	ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)	22q13.1
7039	TGFA	TFGA	transforming growth factor alpha	2p13
5899	RALB	-	v-ral simian leukemia viral oncogene homolog B	2q14.2
6772	STAT1	CANDF7 \| IMD31A \| IMD31B \| IMD31C \| ISGF-3 \| STAT91	signal transducer and activator of transcription 1	2q32.2
7048	TGFBR2	AAT3 \| FAA3 \| LDS1B \| LDS2 \| LDS2B \| MFS2 \| RIIC \| TAAD2 \| TGFR-2 \| TGFbeta-RII	transforming growth factor beta receptor II	3p22
5894	RAF1	CMD1NN \| CRAF \| NS5 \| Raf-1 \| c-Raf	Raf-1 proto-oncogene, serine/threonine kinase	3p25
5291	PIK3CB	P110BETA \| PI3K \| PI3KBETA \| PIK3C1	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta	3q22.3
5337	PLD1	-	phospholipase D1	3q26
5290	PIK3CA	CLOVE \| CWS5 \| MCAP \| MCM \| MCMTC \| PI3K \| p110-alpha	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha	3q26.3
5602	MAPK10	JNK3 \| JNK3A \| PRKM10 \| SAPK1b \| p493F12 \| p54bSAPK	mitogen-activated protein kinase 10	4q22.1-q23
4790	NFKB1	CVID12 \| EBP-1 \| KBF1 \| NF-kB1 \| NF-kappa-B \| NF-kappaB \| NFKB-p105 \| NFKB-p50 \| NFkappaB \| p105 \| p50	nuclear factor of kappa light polypeptide gene enhancer in B-cells 1	4q24
1950	EGF	HOMG4 \| URG	epidermal growth factor	4q25
5295	PIK3R1	AGM7 \| GRB1 \| IMD36 \| p85 \| p85-ALPHA	phosphoinositide-3-kinase regulatory subunit 1	5q13.1
7422	VEGFA	MVCD1 \| VEGF \| VPF	vascular endothelial growth factor A	6p12
1871	E2F3	E2F-3	E2F transcription factor 3	6p22
1956	EGFR	ERBB \| ERBB1 \| HER1 \| NISBD2 \| PIG61 \| mENA	epidermal growth factor receptor	7p12
5898	RALA	RAL	v-ral simian leukemia viral oncogene homolog A (ras related)	7p15-p13
5879	RAC1	MIG5 \| Rac-1 \| TC-25 \| p21-Rac1	ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)	7p22
1021	CDK6	MCPH12 \| PLSTIRE	cyclin-dependent kinase 6	7q21-q22
673	BRAF	B-RAF1 \| BRAF1 \| NS7 \| RAFB1	B-Raf proto-oncogene, serine/threonine kinase	7q34
3551	IKBKB	IKK-beta \| IKK2 \| IKKB \| IMD15 \| NFKBIKB	inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta	8p11.2
1029	CDKN2A	ARF \| CDK4I \| CDKN2 \| CMM2 \| INK4 \| INK4A \| MLM \| MTS-1 \| MTS1 \| P14 \| P14ARF \| P16 \| P16-INK4A \| P16INK4 \| P16INK4A \| P19 \| P19ARF \| TP16	cyclin-dependent kinase inhibitor 2A	9p21
5900	RALGDS	RGDS \| RGF \| RalGEF	ral guanine nucleotide dissociation stimulator	9q34.3